GW-3965-PEG-5-VH-032 | Interleukin Related interleukin-related.com

Product Name :
GW-3965-PEG-5-VH-032

Search keywords :
GW3965

drugId :
null

Target Vo:
Liver X receptor

Target Vo Short Name :
LXR

Moa_Name:
Liver X receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Yokohama City University

Active Company_Name :
Yokohama City University

Active Indication_Name:

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Heme Oxygenase 1(HO-1) Rabbit mAb custom synthesis
Casirivimab Purity & Documentation
CPT1A Antibody: CPT1A Antibody is an unconjugated, approximately 86 kDa, rabbit-derived, anti-CPT1A polyclonal antibody. CPT1A Antibody can be used for: WB, ELISA expriments in mouse, and predicted: human, rat background without labeling.

Author: Interleukin Related

Related Posts